首页> 外文期刊>South African medical journal: Suid-Afrikaanse tydskrif vir geneeskunde >Guideline for the management of chronic asthma in children--2000 update. Allergy Society of South Africa Working Group.
【24h】

Guideline for the management of chronic asthma in children--2000 update. Allergy Society of South Africa Working Group.

机译:儿童慢性哮喘管理指南-2000年更新。南非过敏学会工作组。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To increase awareness of asthma and diagnose asthma early in children. To make recommendations regarding management of chronic childhood asthma in a country with diverse cultural, socio-economic and educational characteristics. The guideline should be used by health professionals involved in the treatment of asthma at all levels of care. OPTIONS: Various management options were considered. Ideal treatment includes use of the new generation inhaled corticosteroids (fluticasone, budesonide), housedust mite intervention for asthma control using impermeable covers for pillows and mattresses, and if needed use of inhaled long-acting beta 2 agonists (LABAs) and leukotriene receptor antagonists (LRAs). Alternative therapeutic approaches for situations where resources are limited include simple housedust mite control measures (e.g. airing mattresses and bedding), avoidance of exposure to passive smoking, use of lower doses of beclomethasone than recommended by other guideline documents and/or sustained-release (SR) theophylline as preventer treatment and use of plastic bottles as cheap spacer devices. OUTCOMES: The main potential outcomes considered were: to reduce morbidity and mortality by correct diagnosis of asthma, to achieve the best quality of life for the child with asthma, to minimise side-effects from medication and to prevent development of permanently abnormal lung function. EVIDENCE: Current international guideline documents for diagnosis and management of childhood asthma were evaluated. Clinical studies before 1998 pertaining to the various aspects of management of childhood asthma were reviewed, including controlled studies on the use of inhaled corticosteroids in children with asthma, randomised controlled trials on the use of LRAs and two studies evaluating the efficacy of LABAs. Current data on the anti-inflammatory effects of SR theophylline were also reviewed as well as a randomised controlled trial on the benefits of SR theophylline as adjunct treatment in childhood asthma. The benefit of simple spacer devices, based on well-conducted local studies (published in an international peer-reviewed journal) was also considered. VALUES: The South African Childhood Asthma Working Group (SACAWG) committee members, appointed by the Allergy Society of South Africa (ALLSA), were selected to represent the interests of health professionals involved in the care of childhood asthma and to co-opt other colleagues with expertise relevant to the guideline. The committee was divided into six task groups headed by a chairperson--each task group had to review critically the previous SACAWG guideline (for deficiencies and obstacles to implementation), review current trends in asthma management (evidence-based where available) and submit proposals and recommendations to their respective chairperson. The chairperson then compiled a report for discussion by the SACAWG executive committee. The executive group convened a meeting to discuss the recommendations and obtain consensus. An editorial board was appointed to compile the final report. Cultural factors, patient preferences, cost, availability and education were considered important. BENEFITS, HARMS AND COSTS: Proper treatment should enable most children with asthma to lead normal or near-normal lives. The guideline could be implementable at all levels of care. The risk of systemic effects due to inhaled corticosteroids should be minimised in children with mild to moderate persistent asthma (risk of systemic effects is more likely at daily beclomethasone doses exceeding 400 micrograms or the equivalent dose of other inhaled corticosteroids). Promotion of simple environmental control measures and use of inhaled beclomethasone and/or SR theophylline should make treatment more widely available and more affordable and improve adherence to treatment. Alternative cheap plastic bottle spacer devices will increase availability and assist with overcoming the problem of incorrect inha
机译:目的:提高儿童对哮喘的认识并尽早诊断哮喘。就具有不同文化,社会经济和教育特征的国家中的慢性儿童哮喘的治疗提出建议。在所有级别的护理中,参与哮喘治疗的卫生专业人员均应使用该指南。选择:考虑了各种管理选择。理想的治疗方法包括使用新一代吸入性皮质类固醇(氟替卡松,布地奈德),使用螨虫枕头和床垫进行室内尘螨干预以控制哮喘,以及在需要时使用吸入的长效β2激动剂(LABAs)和白三烯受体拮抗剂( LRAs)。在资源有限的情况下,其他治疗方法包括简单的屋尘螨控制措施(例如,通风的床垫和床上用品),避免被动吸烟,使用比其他指南文件建议的剂量更低的倍氯米松和/或缓释(SR) )茶碱作为预防剂,使用塑料瓶作为廉价的隔离装置。结果:考虑的主要潜在结果是:通过正确诊断哮喘来降低发病率和死亡率,为哮喘患儿实现最佳生活质量,最大程度地减少药物副作用并防止永久性肺功能异常。证据:评估了有关儿童哮喘的诊断和管理的最新国际指南文件。回顾了1998年之前有关儿童哮喘治疗各个方面的临床研究,包括哮喘儿童吸入皮质类固醇使用的对照研究,LRA使用的随机对照试验以及两项评估LABA疗效的研究。还综述了有关SR茶碱抗炎作用的最新数据,以及有关SR茶碱作为儿童哮喘辅助治疗益处的随机对照试验。还考虑了基于进行良好的本地研究(在国际同行评审的杂志上发表)的简单间隔装置的好处。价值:由南非过敏学会(ALLSA)任命的南非儿童哮喘工作组(SACAWG)委员会成员被选为代表参与儿童哮喘治疗的卫生专业人士的利益,并与其他同事共同选择具有与指南相关的专业知识。该委员会分为六个工作组​​,由主席主持,每个工作组都必须严格审查SACAWG以前的指南(针对实施中的不足和障碍),审查哮喘管理的当前趋势(在可用的情况下以证据为基础)并提交提案和对各自主席的建议。然后,主席编写了一份报告,供SACAWG执行委员会讨论。执行小组召集会议讨论建议并取得共识。任命了编辑委员会来编写最终报告。文化因素,患者喜好,费用,可及性和教育被认为很重要。好处,危害和费用:正确的治疗应使大多数哮喘儿童过正常或接近正常的生活。该指南可以在所有护理级别上实施。对于轻度至中度持续性哮喘的儿童,应将吸入糖皮质激素引起的全身性影响的风险降至最低(每日倍氯米松剂量超过400微克或同等剂量的其他吸入糖皮质激素的全身性发生风险的可能性更大)。推广简单的环境控制措施和使用吸入的倍氯米松和/或SR茶碱可以使治疗更广泛,更便宜,并提高对治疗的依从性。替代性的廉价塑料瓶垫片设备将提高可用性,并有助于解决不正确的吸入问题

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号